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Abstract 
Knowledge of the atomic resolution structures of the respiratory enzymes from mammalian mitochondria s likely to be essential for 
understanding the molecular basis of human diseases involving their dysfunction. Because they are membrane-bound multisubunit 
assemblies, the determination of their high resolution structures i  a rather challenging undertaking. The greatest progress has been made 
with the ATP synthase. The structure of its catalytic domain, F1-ATPase, has been solved by X-ray crystallography at 2.8 ,~ resolution. It 
supports a binding change mechanism of catalysis in intact ATP synthase in which the catalytic subunits are in different states of the 
catalytic ycle at any instant. Interconversion f the states may be achieved by rotation of an a-helical domain of the y-subunit relative to 
the a 3/33 sub-assembly. The membrane domain of ATP synthase has been purified, and the stalk linking the catalytic and membrane 
domains has been reassembled in vitro from its constituent subunits. Considerable progress has also been made in analyzing the structure 
of bovine complex I. It has about 43 different subunits and 42 of them have been sequenced. All of the known prosthetic groups have 
been localized in its extrinsic membrane arm, which has been split away from the membrane subunits and purified. The next stage is to 
crystallize the domain and to solve its structure. 
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1. Introduction 
In his recent book [1], Max Perutz has described the 
many medical benefits that have come from knowledge of 
the atomic structure of hemoglobin. It has led to an 
understanding of the molecular pathologies of thalasemias 
and anemias, it has influenced drug design (for reduction 
of oxygen affinity of hemoglobin, for example), and it has 
provided the basis for engineering a hemoglobin infusible 
as a blood substitute. Therefore, it is reasonable to suppose 
that detailed knowledge of the structures of the five respi- 
ratory enzyme complexes in the inner membranes of mito- 
chondria (Table 1) would eventually bring comparable 
benefits to the understanding and management of human 
diseases arising from dysfunction of mitochondrial respira- 
tory complexes [2-5]. With the exception of succinate 
dehydrogenase, each respiratory complex has one or more 
of its subunits encoded in mitochondrial DNA (Table 1). 
Therefore, these enzymes can be affected by mitochondrial 
DNA mutations, either inherited from maternal mito- 
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chondria or arising by sporadic somatic mutation [5]. As 
about 40% of human mitochondrial DNA is given over to 
encoding 7 of its subunits, complex I is the respiratory 
enzyme most likely to be affected by mitochondrial DNA 
mutations and to be involved in human diseases. There- 
fore, the determination of its high resolution structure is 
particularly important. 
The accumulation of somatic mutations during life is 
much more rapid in mitochondrial DNA than in nuclear 
genes, possibly because of DNA damage caused by oxy- 
gen radical generation in the organelle [5-7], coupled with 
the absence of a mitochondrial DNA excision repair mech- 
anism [7]. Specific mutations in mitochondrial DNA and 
loss of respiratory functions are associated with some 
medically defined syndromes associated with neuromuscu- 
lar defects [2-5]. Mitochondrial DNA mutations accumu- 
lated during life and leading to a gradual loss of ATP 
production, have been linked to ageing [6,7], to Alzheimer's 
disease and Parkinson's disease [5,8,9]. Impairment of 
complex I activity in the mitochondria of the Substantia 
nigra and consequent loss of dopaminergic neurones in 
Parkinson's disease, could be a consequence of either 
mitochondrial DNA mutation, or selective uptake and ac- 
cumulation of toxic xenobiotics [8,9]. 
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Table 1 
Subunit compositions of respiratory complexes from bovine mitochondria 
Complex Subunits 
Nuclear Mitochondrial (n mes) 
I > 34 7 (NDI-ND6, ND4L) 
II 4 0 
III 10 1 (cytochrome b) 
IV 13 3 (Cox I, II, lid 
V 16 2 (A6L, ATPase-6) 
Synonyms: Complex I, NADH: ubiquinone oxidoreductase; complex II,
succinate dehydrogenase-ubiquinone reductase; complex III, cytochrome 
bc t , or ubiquinol-cytochrome c r ductase; complex IV, cytochrome c 
oxidase; complex V, ATP synthase. 
Considerable progress has been made towards the goal 
of determining the structures of mammalian respiratory 
enzymes, and with the exception of a single subunit of 
complex I, the primary structures of all of the subunits of 
the complexes have been determined. Nonetheless, two 
common features continue to impede progress towards 
obtaining atomic resolution structures of respiratory en- 
zymes, namely their complexity (see Table 1) and their 
membrane association. 
The most extreme example of the complexity of a 
respiratory enzyme is provided by the aptly named com- 
plex I. The bovine enzyme is an assembly of about 43 
different subunits with a combined molecular mass of 
nearly 10 6 [10]. It also contains bound FMN and between 
5-7 iron-sulphur clusters [10,11]. Therefore, the produc- 
tion of a completely homogeneous complex containing a
full complement of subunits and prosthetic groups, as is 
desirable for crystallization, is difficult. To prove by bio- 
chemical analysis that a preparation of an enzyme complex 
has all the necessary components in full stoichiometric 
amounts, is equally technically demanding. 
2. Membrane protein structural analysis by X-ray crys- 
tallography 
The major practical difficulty to be overcome in struc- 
tural analysis of membrane proteins by X-ray crystallogra- 
phy is to produce crystals diffracting X-rays to high resolu- 
tion. The crystallization and structural analysis of bacterial 
photosynthetic reaction centres [12] over 10 years ago gave 
rise to optimism that it would be possible to make suitable 
crystals of other membrane proteins. However, with the 
notable xceptions of bacterial porins [13,14], photosystem 
I from Synechococcus elongatus [15] and prostaglandin 
synthase from the endoplasmic reticulum [16], disappoint- 
ingly little progress has been made in the intervening 
period in analyzing membrane-bound proteins in this way. 
Many attempts have been made to produce three-dimen- 
sional crystals of the intact respiratory enzymes. The most 
promising are crystals of bovine cytochrome bc~ complex, 
which are reported to diffract X-rays to 2.9 ,~ resolution 
[17]. Crystals of cytochrome c oxidase have also been 
described [18,19], but no 3-dimensional crystals have been 
reported of either intact ATP synthase or complex I. 
3. Over-expression of membrane proteins 
Crystallization and structural analysis of globular pro- 
teins have been greatly aided by the development of 
expression vectors allowing them to be made in large 
amounts in various hosts, and particularly in bacteria. 
Frequently, the over-expressed proteins can be isolated 
rapidly, in abundance and in a very pure and active state. 
In other cases, the over-expressed protein accumulates as 
inclusion bodies in the bacterial cytoplasm, and often the 
native protein can be recovered by refolding it in vitro. 
The availability of protein samples produced by over-ex- 
pression permits wide exploration of crystallization param- 
eters, allowing experimental conditions for crystal forma- 
tion to be identified rapidly. The formation of crystals is 
also probably helped by the high purity of the proteins. 
The limited success in making 3-dimensional crystals of 
membrane proteins may be due in part to the tack of 
abundant sources of many membrane proteins. Some of 
them have been produced by over-expression in eukaryotic 
cells (yeast cells, Xenopus laevis oocytes) or in eukaryotic 
viral vectors, but, in general, the levels of expression that 
have been achieved are rather low [20]. 
Over-expression of numerous membrane proteins in 
bacteria has also been attempted, but many foreign mem- 
brane proteins are toxic to Escherichia coli, and induction 
of their expression almost always impairs or prevents 
bacterial division [20]. Even over-expression f its own 
membrane proteins can be toxic to the bacterium. There- 
fore, if toxicity of membrane protein expression is to be 
circumvented, the basis of the toxicity needs to be under- 
stood. Recently, a few bacterial proteins [21], and even 
membrane proteins from mammalian mitochondria [22] 
have been produced at quite high levels in E. coli, and 
these results may provide an impetus for future develop- 
ments. 
As the mitochondrial respiratory enzymes are quite 
abundant, he development of bacterial expression systems 
for making their membrane subunits would not appear at 
first sight to be of high priority. However, the benefit of 
having systems for high level expression of membrane 
proteins is that it would be likely to allow a wider range of 
successful crystallization conditions to be established with 
simpler membrane proteins, and that these conditions may 
then prove helpful with larger membrane associated com- 
plexes. Another benefit would be that the biochemical nd 
biophysical properties of the individual membrane subunits 
of the multi-subunit complexes could be studied, and their 
interactions with other subunits could be established, for 
example by in vitro reconstitution experiments. 
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4. Structural analysis by electron diffraction using 2-di- 
mensional crystals 
The most important recent advances in membrane pro- 
tein structure determination have been made by electron 
diffraction studies of 2-dimensional crystals, culminating 
in molecular models of bacteriorhodopsin [23] and of the 
light harvesting complex from chloroplasts [24] at 3.5 and 
3.4 A resolution, respectively, and in a model of the 
acetylcholine receptor at 9 A resolution [25]. As the pro- 
duction of adequate 2-dimensional crystals seems to be 
easier and less demanding of starting material than 3-di- 
mensional crystallization, this approach might prove to be 
a general avenue for progress in membrane structure deter- 
mination. An important advantage of electron diffraction 
methods is that the phases of structure factors are deter- 
mined directly from the Fourier transforms of electron 
micrographs, and therefore it is not necessary to prepare 
isomorphous heavy atom derivatives, as is required for 
structure determination by X-ray crystallography [26]. 
Two-dimensional crystals of complex I, of ubiquinol- 
cytochrome c reductase and of cytochrome c oxidase have 
all been analyzed, and have given information about the 
general shapes of the enzyme complexes. From measure- 
ments of crystals of Neurospora crassa complex I in 
negative stain, complex I was shown to be shaped like the 
letter L, with one arm in the membrane and the other one 
protruding into the mitochondrial matrix [27]. A low reso- 
lution structure of cytochrome bc] was calculated from 
negatively stained crystals, but the crystals were limited to 
25 A resolution in the plane of the membrane [28]. The 
most extensive analyses were conducted on the cy- 
tochrome c oxidase crystals in vitreous ice. A model at 20 
,~ resolution was obtained, and it was demonstrated that 
the crystals were intrinsically ordered to 10 ~, resolution at 
best [29]. Therefore, if the structure is to be extended to 
higher resolution, improved 2-dimensional crystals must 
first be prepared. 
5. Structural analysis of ATP synthase 
Bovine ATP synthase is an assembly of 16 different 
polypeptides of known sequence [30,31], some of them 
present in multiple copies. Its global structure was first 
described in 1962, when it was observed that the inner 
membranes of bovine heart mitochondria are lined with 90 
,~ particles facing the matrix [32]. These particles have 
sometimes been described as lollipops since the spherical 
heads are attached to the membrane by a slender stalk 
40-50 A long. Disruption of the stalk releases the heads as 
the water soluble sub-complex Fj-ATPase, which retains 
structural integrity and an ATP hydrolase activity [33]. In 
the presence of an essential component of the stalk known 
as the oligomycin sensitivity conferral protein (OSCP), 
F~-ATPase can be re-associated with the membrane do- 
main, and the original membrane-bound structure re-as- 
sembles [34]. The membrane domain, known as Fo, con- 
tains a transmembrane proton transporting mechanism that 
provides energy for ATP synthesis. The energy is trans- 
ferred to the catalytic sites in F 1, probably by long-range 
conformational changes passing via the stalk [35]. 
The splitting of ATP synthase into its globular and 
membrane domains provides the basis of the strategy being 
pursued for determining its structure, and, not surprisingly, 
greater progress has been made with the Fj globular 
domain. It is made of five different proteins, o~, /3, y, 6 
and c with stoichiometries of 3:3:1:1:1, respectively. The 
catalytic sites of ATP synthase are in the /3-subunits. The 
homologous o~-subunits also contain nucleotide binding 
sites, but the nucleotides are firmly bound. They do not 
exchange during catalysis, and their roles remain mysteri- 
ous [36]. 
Recently, the atomic structure of F]-ATPase from bovine 
heart mitochondria has been established by X-ray crystal- 
lography [37], using crystals grown in the prese~ce of both 
ADP and the ATP analogue, adenylylimido-diphosphate 
(AMP-PNP) [38]. In this structure (see Fig. 1), the three 
catalytic /3-subunits have different conformations and nu- 
cleotide contents: one of them contains AMP-PNP, the 
second ADP and the third is distorted and empty. There- 
fore, the structure is in accord with a binding change 
mechanism of ATP synthesis, which proposes that at any 
instant he catalytic sites are in different states, but each of 
them passes through the same cycle of interconverting 
states [39]. Thus, all three catalytic sites are equipotent. In
order to obtain more details of these interconversions, it 
will be necessary to solve the structures of other conforma- 
tional states of the enzyme, which first must be crystal- 
lized. 
The structure of Fj-ATPase [37] also provides important 
clues about how the energy is transferred from Fo to the 
catalytic sites. The entire Fj assembly is traversed by a 
single ce-helix made from the C-terminal region of the 
y-subunit. This helix extends out of the spherical part of Fj 
made of the 3c~ and 3/3 subunits into a region that is 
almost certainly a vestige of the stalk in the intact ATP 
synthase. Around the lower part of this o~-helix is wrapped 
a second c~-helix (also part of the y-subunit). Together 
they form an anti-parallel coiled-coil structure. These he- 
lices are likely to be part of the energy transmission 
machinery for bringing energy to the catalytic sites. The 
atomic model does not include the 3 and ~ subunits, 
although they are present in the crystals. It appears that 
they, and 145 amino acids of the y-subunit, are insuffi- 
ciently ordered to permit interpretation of the electron 
density in the vicinity of the protrusion of the coiled-coil 
from the lower end of the structure. 
In the intact membrane-bound bovine enzyme, the stalk 
is formed from part of the y-subunit (and probably sub- 
units 3 and e) in co-assembly with other subunits, includ- 
ing the OSCP, F 6, subunit b and subunit d. A 'stalk' 
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complex containing these latter four proteins has been 
reconstituted in vitro, both in the presence of F~-ATPase 
and in its absence, using subunits produced by heterolo- 
gous expression i  E. coli [40]. It is hoped that the 'stalk' 
and F~. 'stalk' complexes will enable the high resolution 
structure to be extended into the region linking F~ with the 
intrinsic membrane sector of the enzyme. 
About the structure of F o little is known, but bovine F,, 
a 
O~Dp 
c d 
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Fig. 2. Structural model of complex I. A montage of views of reconstructions of the extrinsic and membrane arms of complex I from N. crassa is shown 
[27]. The parallel lines indicate the lipid bilayer. It is likely that bovine complex I has a similar shape. Reproduced with permission from [27]. 
can be easily purified from mitochondria in reasonable 
yield and in a monodisperse form [31], as can the intact 
FtF,,-ATPase complex [41]. Therefore, sufficient material 
is available to allow various biochemical, biophysical and 
crystallization studies to be performed on the membrane 
associated complexes. 
6. Structural analysis of complex I
Like ATP synthase, the L-shaped complex I also has an 
extensive globular domain attached to an intrinsic mem- 
brane domain (see Fig. 2). Therefore, a similar strategy of 
studying the globular domain separately from the mem- 
brane domain is being pursued. However, the high resolu- 
tion structural analysis is not as advanced as with the ATP 
synthase. The first problem, which has now been over- 
come, is how to separate the two domains from each other. 
It has long been known that bovine complex I can be 
disrupted by the chaotropic anion, perchlorate, giving rise 
to three fractions known as the flavoprotein (FP), iron- 
sulphur protein (IP) and hydrophobic protein (HP) frac- 
tions [42]. The FP fraction is the most important, since it 
retains the ability to transfer electrons from NADH to the 
artificial electron acceptor, ferricyanide [11,42], whereas 
the IP and HP fractions have no known enzymic activities. 
The FP fraction consists of only three of the subunits of 
complex I, the 51, 24 and 10 kDa subunits in stoichio- 
metric association [11,42]. The 51 kDa subunit contains 
the binding sites for NADH and the primary electron 
acceptor, FMN, and also binds a tetranuclear iron-sulphur 
centre, a binuclear iron-sulphur centre is associated with 
the 24 kDa subunit, and the 10 kDa subunit has no known 
functions. Therefore, the FP fragment probably contains 
the first part of the electron pathway in complex I, and 
knowledge of its structure would contribute to a deeper 
understanding of the mechanism of complex I. Unfortu- 
nately, the yields of pure material that can be recovered 
from bovine heart mitochondria are rather low, and there- 
fore it would be helpful if this fragment could be made, for 
example by re-assembly of its constituent proteins made 
by heterologous expression i  bacteria. 
Recently, bovine complex I has been split into two 
fragments in the presence of the detergent lauryl dimeth- 
ylamine oxide [43]. The fragments are known as sub-com- 
plexes I a and I/3. The former can transfer electrons from 
NADH to co-enzyme Qj, and therefore, as its EPR spectra 
also confirm, it appears to have retained a substantial part 
of the electron pathway of complex I [43]; no known 
activity is associated with sub-complex 1/3. Subcomplex 
I a consists of about 23 of the subunits of complex I, and 
it is evident from their sequences that most of them are 
Fig. 1. The structure of F t-ATPase from bovine heart mitochondria at2.8 ,~ resolution. The a-, /3- and y-subunits are red, yellow and blue, respectively, 
and nucleotides are black, in ball and stick representation. AMP-PNP is bound to the three o~-subunits, and to the /3-subunit defined as /3~. Subunit /3DP 
has bound ADP and subunit fiE has no associated nucleotide. Therefore, the structure probably represents he ADP inhibited state of the enzyme. (A) A 
view of the entire F I particle in which subunits a E and fiE point towards the viewer, revealing the anti-parallel coiled-coil of the N- and C-terminal 
helices of the y-subunit through the open interface between them. The bar is 20 ,~ long. (B) Subunits aTp, 7 and flop from a similar viewpoint to (A), but 
rotated 180 ° about the axis of pseudo-symmetry. ADP.Mg but no phosphate is bound to subunit /3oP. (C) Subunits a E, y and flTr' from a similar 
viewpoint o (A), but rotated by -60  °. The asterisk denotes the loop containing the DELSEED sequence with which the ATPase inhibitor protein is 
thought to interact. (D) Subunits Otop, y, and /3E from a similar viewpoint to (A), but rotated by 60 ° . The arrow indicates the disruption of the /3-sheet in 
the nucleotide binding domain, which prevents it from binding nucleotide. For other details, see [37]. 
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globular proteins, as they lack extensive hydrophobic re- 
gions. Nonetheless, a few hydrophobic proteins are present 
in the sub-complex, and detergent is required to keep it 
soluble. By modification of the procedure for splitting 
bovine complex I into subcomplexes I a and I/3, a simpler 
active sub-complex named I A can be recovered (M. Finel, 
J.M. Skehei, S.J.P. Albracht and J.E. Walker, unpublished 
data). This sub-complex retains the ability to transfer 
electrons to ferricyanide, but not to quinones. Its EPR 
spectrum contains signals representing all of the known 
spectroscopically characterized iron-sulphur clusters of the 
enzyme, although the signal attributed to cluster N-2 is 
broadened, suggesting that the removal of sub-complex I A 
from the membrane has affected its environment. Sub- 
complex IA contains 14 of the subunits of complex I, 
including the three subunits of the FP fraction, and the 
iron-sulphur proteins, the 75 kDa subunit and subunit 
TYKY. None of the subunits of sub-complex I A is thought 
to be an intrinsic membrane protein, and therefore it 
appears that sub-complex I A represents most of the extrin- 
sic membrane arm of bovine complex I. The EPR spec- 
trum of sub-complex I A is remarkably similar to a prepara- 
tion known as soluble NADH dehydrogenase, made by 
digesting electron transport particles with phospholipase A 
[44]. Polyacrylamide gel analyses of this complex are also 
similar to those of sub-complex I A [45], but the subunit 
composition of the soluble dehydrogenase has not been 
established by protein chemical analysis, and therefore the 
extent of the correspondence b tween sub-complex I A and 
the soluble dehydrogenase i  not known. The next critical 
task is to obtain suitable crystals of either sub-complex I A, 
or possibly of the FP fragment of complex I. 
7. Conclusions 
The structural analysis of the two respiratory enzymes, 
ATP synthase and complex I from bovine mitochondria 
are being pursued by related strategies. Both of them 
consist of two main structural domains, one buried within 
the inner membrane of the mitochondrion, the other at- 
tached to it and protruding into the mitochondrial matrix. 
Therefore, in each case, the two domains can be separated 
and studied apart. A similar strategy is being used with 
cytochrome c oxidase and with the related bacterial cy- 
tochrome o quinoi oxidase In both enzymes, the CuA site 
is found in the same location, in an extrinsic globular 
domain in the carboxy-terminal region of subunit II and 
Cyo A, respectively. Carboxy-terminal fragments of sub- 
unit II from Paracoccus denitrificans cytochrome oxidase 
and Cyo A from E. coli have been over-expressed in E. 
coli. The Cyo A fragment has been crystallized, and the 
crystals diffract X-rays to beyond 2.5 A resolution [46]. 
In the ATP synthase complex, the extrinsic globular 
domain, F1-ATPase, has been solved to atomic resolution 
by X-ray crystallography, the F o membrane domain has 
been purified, and the stalk connecting the two domains 
has been re-assembled in vitro from bacterially made 
subunits. The globular domain of bovine complex I has 
been purified, and its prosthetic groups and subunit com- 
position have been characterized. These are all important 
steps towards the goal of determining the atomic resolution 
structures of these complex enzymes. 
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